TY  - BOOK
AU  - Arboleda,M
AU  - Berman,JD
AU  - English,CK
AU  - Grogl,M
AU  - Gutierrez,P
AU  - Nicholls,RS
AU  - Padilla,JR
AU  - Soto,JM
AU  - Toledo,JT
TI  - Treatment of cutaneous leishmaniasis with a topical antileishmanial drug (WR279396): phase 2 pilot study 
CY  - Ohio
KW  - Leishmaniasis cutánea
KW  - Administración tópica
KW  - Bibliografía del INS4
KW  - Terapia combinada
N2  - We studied the efficacy of WR279396, a topical formulation of aminoglycosides that cures 100 per cent of cutaneous leishmaniasis lesions in mice. We conducted what is to our knowledge the first controlled study of WR279396 therapy for clinical cutaneous l
ER  -